The World Health Organization (WHO) has introduced new guidelines for antibiotic production to address the growing issue of antibiotic resistance.
The WHO highlighted concerns about the environmental impact of pharmaceutical waste, noting that active substances from drug manufacturing often end up in wastewater, which can foster the development of antibiotic-resistant bacteria.
These bacteria can cause infections that are difficult to treat due to limited effective therapies.
Resistance can also arise from excessive use of antibiotics or incomplete treatment courses.
The WHO’s new recommendations focus on pharmaceutical manufacturers, stressing the need for strict control over wastewater management.
 Regulatory bodies are urged to enforce stricter environmental standards for approving pharmaceutical production.
Additionally, the WHO advocated for increased transparency in the industry, enabling investors, buyers, and patients to better understand the environmental measures taken by drug companies.
 Patients are encouraged to dispose of unused medications properly, avoiding flushing them down toilets or sinks.
 Many locations allow for the disposal of old medications with general waste, and some pharmacies offer proper disposal services.
